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Proteomics, University of California, Los Angeles, Los Angeles, California, USAc; Department of Molecular Microbiology and Immunology, The Johns Hopkins University
Bloomberg School of Public Health, Baltimore, Maryland, USAd; Molecular Biology Institute, University of California Los Angeles, Los Angeles, California, USAe
ABSTRACT Toxoplasma gondii is an obligate intracellular parasite that invades host cells and replicates within a unique parasi-
tophorous vacuole. Tomaintain this intracellular niche, the parasite secretes an array of dense granule proteins (GRAs) into the
nascent parasitophorous vacuole. These GRAs are believed to play key roles in vacuolar remodeling, nutrient uptake, and im-
mune evasion while the parasite is replicating within the host cell. Despite the central role of GRAs in the Toxoplasma life cycle,
only a subset of these proteins have been identified, andmany of their roles have not been fully elucidated. In this report, we uti-
lize the promiscuous biotin ligase BirA* to biotinylate GRA proteins secreted into the vacuole and then identify those proteins by
affinity purification andmass spectrometry. Using GRA-BirA* fusion proteins as bait, we have identified a large number of
known and candidate GRAs and verified localization of 13 novel GRA proteins by endogenous gene tagging. We proceeded to
functionally characterize three related GRAs from this group (GRA38, GRA39, and GRA40) by gene knockout. Whilegra38 and
gra40 parasites showed no altered phenotype, disruption ofGRA39 results in slow-growing parasites that contain striking lipid
deposits in the parasitophorous vacuole, suggesting a role in lipid regulation that is important for parasite growth. In addition,
parasites lacking GRA39 showed dramatically reduced virulence and a lower tissue cyst burden in vivo. Together, the findings
from this work reveal a partial vacuolar proteome of T. gondii and identify a novel GRA that plays a key role in parasite replica-
tion and pathogenesis.
IMPORTANCE Most intracellular pathogens reside inside a membrane-bound vacuole within their host cell that is extensively
modified by the pathogen to optimize intracellular growth and avoid host defenses. In Toxoplasma, this vacuole is modified by a
host of secretory GRA proteins, many of which remain unidentified. Here we demonstrate that in vivo biotinylation of proximal
and interacting proteins using the promiscuous biotin ligase BirA* is a powerful approach to rapidly identify vacuolar GRA pro-
teins. We further demonstrate that one factor identified by this approach, GRA39, plays an important role in the ability of the
parasite to replicate within its host cell and cause disease.
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Toxoplasma gondii is an intracellular parasite that is capable ofinfecting virtually all warm-blooded animals and nearly any
mammalian cell type (1). Human infection is estimated at approx-
imately 30% of the world’s population, although rates vary widely,
depending on geographical location (2). Most humans have no
manifestation of chronic disease (asymptomatic infection), al-
though in the acute phase, many will develop flu-like symptoms,
including fever, lymphadenitis, and fatigue. Immunocompro-
mised individuals, such as those with HIV infection, solid organ or
hematopoietic stem cell transplant, or those on high-dose steroid
therapy, are subject to dire end organ diseases, including eye dis-
ease (retinitis) and central nervous system disease (encephalitis)
(3). Fetuses of mothers with acute or reactivated toxoplasmosis
are also at risk of congenital infection, with manifestations rang-
ing from retinitis to devastating cerebritis and obstructive hydro-
cephalus with consequent global mental and physical disability
(3). Despite our knowledge of this disease over the last 100 years,
there is still much to learn about how Toxoplasma invades host
cells, establishes a replication-competent niche, and acquires nu-
trients from its host cell.
Toxoplasma invasion is mediated by three specialized secretory
organelles, named the micronemes, rhoptries, and dense granules,
which contribute to the parasite’s ability to initiate and sustain
infection within its host (4). The micronemes first secrete an array
of adhesins that facilitate parasite attachment to the surface of the
host cell (5). Second, the club-shaped rhoptries secrete proteins
that enable host cell penetration and vacuole formation, as well as
hijacking of host immune functions (6). Finally, proteins from the
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dense granules are secreted which are implicated in the remodel-
ing and maintenance of the nascent parasitophorous vacuole (PV)
for intracellular survival (7). Although the dense granule pro-
teome is hypothesized to be composed of hundreds of proteins,
only about 30 of these proteins have been discovered, and their
precise roles in intracellular parasite survival and growth are not
well elucidated (8). Thus far, it is known that some dense granule
proteins (GRAs) are integral for the formation and maintenance
of a lipid-based intravacuolar network (IVN), while others are
responsible for the uptake of nutrients from the host cell (9–13).
Recently, a newly discovered class of GRAs has been discovered
that are exported beyond the vacuolar membrane into the host
cytoplasm and modulate host immune and cell cycle activities
(14–17).
To date, most GRAs have been discovered individually by sub-
cellular fractionation of organelles and antibody production,
analysis of excreted or secreted fractions, screening for immuno-
genic peptides, or bioinformatics searches for proteins containing
secretory signal peptides (8, 18). Many of these previously identi-
fied GRAs are extremely abundant or immunogenic, which aided
in their discovery. The more recently discovered class of host cell-
exported GRAs were found in silico by screening for secreted pro-
teins that also contain nuclear localization sequences suggestive of
trafficking to the host cell nucleus or examining for secreted pro-
teins with predicted interaction with the host immune machinery
(14). Although these approaches have been successful, we sought a
method to more rapidly identify a large number of PV compo-
nents. This has been previously difficult as there is no effective
method for purifying the PV without substantial parasite and/or
host contamination.
To address this need, we applied the BioID technique to label
dense granule proteins secreted into the PV. This biochemical
approach utilizes a promiscuous biotin ligase that, when fused to a
“bait” protein, can traffic to an organellar subcompartment and
biotinylate multiple interacting and proximal proteins of the bait
(19). Once biotinylated, the parasites are lysed, and the biotinyl-
ated proteins are purified using streptavidin affinity chromatog-
raphy and identified by mass spectrometry. We have recently used
this approach to identify a number of novel components of the
Toxoplasma inner membrane complex (IMC) (20).
In this report, we show that the BioID system with dense gran-
ule bait proteins can successfully be used to biotinylate and iden-
tify a large number of known and candidate GRAs. From a subset
of this candidate pool, we were able to thus far identify 13 novel
GRAs (GRAs 28 to 40) using C-terminal endogenous gene tagging
and immunofluorescence assays (IFAs), greatly expanding the
known GRA proteome of T. gondii. We then conducted a func-
tional analysis on a group of three related novel GRA proteins
(GRAs 38, 39, and 40) and demonstrate that disruption of GRA39
results in the accumulation of lipid deposits in the parasito-
phorous vacuole and plays a key role in parasite replication, viru-
lence, and cyst burden.
RESULTS
In vivo biotinylation of the PV using GRA proteins as bait. To
identify a large number of vacuolar resident proteins, we adapted
the BioID approach using a secreted GRA protein as bait. To do
this, we created a fusion of the vacuolar pore component GRA17
with the biotin ligase BirA* followed by a C-terminal three-
hemagglutinin (3HA) epitope tag (Fig. 1A) (10). When ex-
pressed inToxoplasma, the GRA17-BirA* fusion trafficked appro-
priately to the PV and colocalized with the known dense granule
protein GRA14 when examined by IFA, indicating that the fusion
did not alter trafficking of GRA17 (Fig. 1B) (21). In addition,
FIG 1 GRA17-BirA* localizes to the PV and can biotinylate proteins in the vacuole. (A) Diagram of the construct encoding the promoter and full genomic
sequence of GRA17 fused to BirA* along with a 3HA C-terminal epitope tag. (B) IFA showing that GRA17-BirA* traffics appropriately to the PV and colocalizes
with GRA14. Scale bar, 10 m (applicable to all panels in panel B). (C) IFA of GRA17-BirA* expressing parasites  biotin, showing the PV is labeled in a
biotin-dependent manner. Endogenously biotinylated apicoplasts are observed with and without biotin (arrowheads). Scale bar, 10m (applicable to all panels
in panel C). (D) Western blot of whole-cell lysates of parental (RH hxgprt) and GRA17-BirA*-expressing parasites  biotin. Lysates were probed with
streptavidin-HRP, revealing an increase in biotinylated proteins in GRA17-BirA*-expressing parasites upon addition of biotin. The GRA17-BirA* fusion protein
is predicted to be ~59 kDa (arrowhead) (10).
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GRA17-BirA* labeled the PV only when biotin was supplemented
(as assessed by streptavidin-fluorescein isothiocyanate [FITC]
staining), demonstrating that the fusion is catalytically active in
this compartment (Fig. 1C). By Western blotting, we found a dra-
matic increase in biotinylated proteins in GRA17-BirA* parasite
lysates, confirming the ability of the GRA17-BirA* fusion to bio-
tinylate a range of targets in the PV (Fig. 1D). Large-scale GRA17-
BioID experiments were then performed on intracellular parasites
with a high multiplicity of infection (~5), which were grown for
~36 h to obtain large vacuoles to maximize labeling of the PV.
These intracellular parasites were harvested and lysed, and biotin-
ylated proteins were purified via streptavidin chromatography.
Compared to a control lysate derived from wild-type parasites
supplemented with biotin, the GRA17-BioID purified fraction re-
vealed a large number of known dense granule proteins (e.g.,
GRAs, MAG1, MAF1, cathepsin, and nucleoside triphosphatase II
[NTPase II]) (7, 8), all of which ranked highly by normalized
spectral abundance factor (NSAF) (Table 1; see Table S1 in the
supplemental material). We therefore concluded that GRA17-
BirA* appropriately labeled PV-resident proteins. In total, the
GRA17-BioID experiment yielded 279 proteins (see Table S1).
While the highest-ranking proteins were mostly GRAs, the lower-
ranked proteins also included other secreted proteins, such as
rhoptry body proteins (ROPs) and rhoptry neck proteins (RONs),
as well as some proteins from the micronemes (MICs) and para-
site surface antigens (SAGs) that would be exposed to the PV.
To expand our studies beyond labeling with GRA17, we gen-
erated two additional BioID constructs—a GRA25-BirA* fusion
and a previously unpublished GRA13 (TgME49_237880)-BirA*
fusion (see Fig. 2 below for IFA of GRA13-HA). These constructs
were expressed in Toxoplasma (see Fig. S1 in the supplemental
material), and then the in vivo biotinylation and purification were
performed as in the GRA17-BirA* experiment. We again found by
tandem mass spectrometry (MS/MS) analysis that many of the
known components of the PV were purified and scored high by
spectral count and unique peptide count (Table 2 and Table 3; see
Tables S2 and S3 in the supplemental material). When we exam-
ined our collective data sets for common proteins, we found sub-
stantial (but not complete) overlap between these data sets (see
Table S4 in the supplemental material). Between the three GRA-
BioID experiments, we identified most of the known numbered
GRAs and named dense granule proteins, including TgPSD1, NT-
TABLE 1 Summary of known and novel GRAs found by GRA17-BioIDa
Gene ID (TgGT1 no. [ToxoDB version 7.3]) Gene ID (TgGT1 no. [ToxoDB release 25]) Protein name
065990 222170 GRA17
034740 288650 GRA12
083030 227620 GRA2
017550 203310 GRA7
082670 227280 GRA3
032340 290700 GRA25
108770 270240 MAG1
096230 297880 GRA23
115760 232000 GRA30
053770 220950 MAF1
068065 275440 GRA6
014920 220240 GRA31
021860 208830 GRA16
087090 310780 GRA4
072150 212300 GRA32
025470 247440 GRA33
064850 410370, 279100, 279100A, 279100B, 411470, 220950 MAF1-related protein
017570 203290 GRA34
000480 275860 GRA12 (paralog)
051100 239740 GRA14
053780 410370, 279100, 279100A, 279100B, 411470, 220950 MAF1-related protein
037870 286450 GRA5
004030 254470 MYR1
081550 226380 GRA35
053890 410360 MAF1-related protein
039660 213067 GRA36
108780 270250 GRA1
115800 231960 GRA28
004270 254720 GRA8
069040 236890 GRA37
088710 312420 GRA38
102940 251540 GRA9
108120 269690 GRA29
117710 230180 GRA24
065030 221210 Cyclophilin
068050 275470 GRA15
125960.0 215220 GRA22
033840 289380 GRA39
a Novel GRAs 28-40 are highlighted in boldface.
Toxoplasma GRA-BioID Reveals Novel Vacuolar Proteins
July/August 2016 Volume 7 Issue 4 e00808-16 ® mbio.asm.org 3
Pase II, PI-I, cyclophilin, several MAF1 proteins, and MYR1 (Ta-
bles 1, 2, and 3; see Tables S1 to S4). We were not able to detect
GRAs 10, 19, 20, and 21 nor the recently described TgLCAT (22).
We also analyzed the data from the GRA-BioID data sets for
potential interacting or proximal host proteins. In each of the
experiments, a relatively small number of host proteins were iden-
tified (21 for GRA17, 43 for GRA25, and 93 for GRA13). This
could be due to the relative abundance of parasite versus host
targets within the vacuole or the fact that few proteins are actually
in close contact with the BirA* fusions. Only a single host protein,
programmed cell death 6-interacting protein, was in common be-
tween the all three GRA-BioID experiments. Other common hu-
man hits between pairs of BioID experiments are shown in Ta-
ble S5 in the supplemental material.
Identification of novel dense granule proteins from BioID
data sets. Analysis of the GRA-BioID data sets also yielded a large
number of hypothetical proteins (see Tables S1, S2, and S3 in the
supplemental material), which were filtered for likely GRAs by
selecting proteins that contained a predicted signal peptide, were
constitutively expressed, and lacked a C-terminal endoplasmic re-
ticulum (ER) retention signal (K/HDEL) (7, 8). As most GRAs
identified to date also lack similarity to known proteins, we also
selected candidates that lacked obvious functional domains for
verification. This resulted in a list of100 candidates, of which we
chose 15 for localization studies using endogenous gene tagging
(see Tables S1, S2, and S3).
To assess localization of these candidate proteins, we engi-
neered constructs that would recombine a sequence encoding a
3HA tag at the C terminus of each gene’s product and localized
the HA signal by IFA. Of the 15 proteins tested, 13 trafficked to the
PV and colocalized with the dense granule protein GRA14
(TgGT1_231960, TgGT1_269690, TgGT1_232000, TgGT1_
220240, TgGT1_212300, TgGT1_247440, TgGT1_203290, TgGT1_
226380, TgGT1_213067, TgGT1_236890, TgGT1_312420,
TgGT1_289380, and TgGT1_219810) (Fig. 2). We therefore
named these proteins GRAs 28 to GRA40, respectively (Tables 1,
2, and 3; see Tables S1 to S4 in the supplemental material). Intrigu-
ingly, GRA28 (TgGT1_231960) was exported to the host cell and
trafficked to the host nucleus (Fig. 2B). In silico analysis revealed
that this protein indeed contained a predicted nuclear localization
sequence at residues 400 to 410. This protein now joins the new
class of exported dense granule proteins that traffic to the host
nucleus, along with GRAs 16 and 24. Examination of these pro-
teins by BLAST analysis revealed that GRA38, GRA39, and GRA40
shared sequence similarity, although GRA38 and GRA39 were
closer to one another (data not shown). This analysis also detected
two other proteins not found in the GRA-BioID data sets with
similarity to GRAs 38 to 40 (TgGT1_293500 and TgGT1_250790).
As TgGT1_293500 contained a predicted signal peptide, we tagged
this protein, which showed that TgGT1_293500 appeared to lo-
calize the endoplasmic reticulum (data not shown). While
TgGT1_250790 was closest in similarity to GRAs 38 and 39, it did
not contain a signal peptide and so was not further studied.
BLAST analysis also revealed low levels of similarity between
GRAs 35 and 36. Through our verification process, we also tagged
2 other proteins (of 15) from the GRA-BioID data sets which did
FIG 2 Identification of a novel dense granule protein, GRA13, and GRAs 30 to 40 by GRA17-BioID. (A) IFA with rabbit anti-HA antibodies shows strong
staining of the parasitophorous vacuole for each novel GRA that colocalizes with GRA14, demonstrating that these are novel dense granule proteins. Gene
numbers and novel designations are as follows: TgGT1_237880, GRA13; TgGT1_231960, GRA28; TgGT1_269690, GRA29; TgGT1_232000, GRA30;
TgGT1_220240, GRA31; TgGT1_212300, GRA32; TgGT1_247440, GRA33; TgGT1_203290, GRA34; TGGT1_226380, GRA35; TgGT1_213067, GRA36;
TgGT1_236890, GRA37; TgGT1_312420, GRA38; TgGT1_289380, GRA39; and TgGT1_219810, GRA40. Scale bar in upper left-hand panel (GRA13), 10 m
(applicable to all panels in panel A). (B) GRA28 is exported to the host cell and concentrates within the host nucleus. IFA with rabbit anti-HA antibody shows
signal within the nucleus of a host fibroblast infected with GRA28-HA parasites (arrow). A neighboring uninfected host cell is shown for contrast (asterisk). Scale
bar in upper left hand panel, 10 m (applicable to all panels in panel B).
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not localize to the PV: TgGT1_209720 localized to the mitochon-
drion, while TgGT1_304990 localized to the Golgi apparatus (see
Table S1) (data not shown). The remaining candidate proteins
that match our criteria for potential GRAs have yet to be localized.
However, the high frequency of successful GRA proteins in our
verification analysis suggests that many of the remaining candi-
dates are likely to be novel GRAs.
GRAs 38, 39, and 40 are not tightly associated with PVmem-
branes. We chose to analyze the group of GRAs 38, 39, and 40, as
GRA38 was previously found to be antigenic in a human serolog-
ical screen that was performed in collaboration with our lab (23).
Most of the previously described GRA proteins are associated with
the parasitophorous vacuolar membrane or the intravacuolar net-
work inToxoplasma infections. GRAs 38, 39, and 40 lack predicted
transmembrane domains or other readily identifiable sequences
for membrane association, suggesting they are soluble compo-
nents of the vacuole. To assess this experimentally, we performed
Triton X-114 partitioning of intracellular parasites and found that
each of these family members fractionated in the aqueous fraction
(as opposed to the detergent/membrane fraction), demonstrating
that they are not firmly associated with the IVN or PV membrane
(PVM) (Fig. 3). While we cannot exclude the possibility of weak
associations with vacuolar membranes, these data indicate that
this new family of GRA proteins are soluble proteins of the PV.
Targeted disruption of GRAs 38, 39, and 40. To understand
the function of the newly characterized GRAs, we disrupted
GRA38, GRA39, and GRA40 by homologous recombination in
their respective 3HA-tagged parental strains (Fig. 4A). Knock-
out clones were identified that lacked the 3HA tag by IFA
(Fig. 4B) and Western blotting (Fig. 4C) and were verified by PCR
(see Fig. S2 in the supplemental material). Intriguingly, gra39
clones were initially difficult to isolate from a transfected popula-
tion as they were quickly outcompeted by nonhomologous re-
combinants, suggesting these parasites possessed a growth pheno-
type in vitro. However, we were able to obtain a knockout clone
that we subsequently complemented with a construct containing
HA-tagged GRA39 driven from the tubulin promoter (Fig. 5A).
This transgene was targeted to the uracil phosphoribosyltrans-
ferase locus (UPRT) (24), and its expression was confirmed by IFA
and Western blotting using both anti-HA antibodies and anti-
GRA39 polyclonal antibodies. (The complemented strain was
designated GRA39c [Fig. 5B and C; see Fig. S3 in the supplemental
material].)
GRA39 is critical for efficient growth in vitro in type II
T. gondii. Next, we analyzed the overall fitness of our GRA knock-
out parasites using competition growth assays and plaque assays.
Competition growth assays showed that gra39 parasites were
rapidly outcompeted by their GRA39-HA parental line after 7
serial passages (Fig. 5D). Plaque assays similarly revealed that
gra39 mutants produced significantly smaller plaques (~80%
reduction in size) than the GRA39-HA line in human foreskin
fibroblast (HFF) monolayers (Fig. 5E and F). This poor-growth
phenotype in knockout parasites was reversed upon complemen-
tation of GRA39. To investigate this phenotype further, we exam-
TABLE 2 Summary of known and novel GRAs found by GRA25-BioIDa
Gene ID (TgGT1 no. [ToxoDB version 7.3]) Gene ID (TgGT1 no. [ToxoDB release 25]) Protein name
108770.0 270240 MAG1
032340 290700 GRA25
017550 203310 GRA7
083030 227620 GRA2
004030 254470 MYR1
017570 203290 GRA34
102940.0 251540 GRA9
021860 208830 GRA16
081550 226380 GRA35
051100 239740 GRA14
068065 275440 GRA6
115760 232000 GRA30
068050 275470 GRA15
087090 310780 GRA4
039660 213067 GRA36
096230 297880 GRA23
108780 270250 GRA1
014920 220240 GRA31
069040 236890 GRA37
082670 227280 GRA3
000480 275860 GRA12
004270 254720 GRA8
053890 410360 MAF1-related protein
125960 215220 GRA22
053780 410370, 279100, 279100A, 279100B, 411470, 220950 MAF1-related protein
033840 289380 GRA39
115800 231960 GRA28
065990 222170 GRA17
108120 269690 GRA29
117710 230180 GRA24
088710 312420 GRA38
a Novel GRAs 28-40 are highlighted in boldface.
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ined the rate of division of parasites during intravacuolar growth.
We found that the gra39 line replicated at a lower rate than
GRA39-HA and GRA39c parasites and also had a substantial
number of parasites that appeared to have died early upon inva-
sion (see below). At the end of 36 h, we found that ~8% ofgra39
parasite vacuoles contained16 parasites per vacuole, compared
to 36% for GRA39-HA vacuoles (Fig. 4G). Consistent with our
plaque assay results, this reduced replication rate was reversed
upon complementation. Of the gra39 vacuoles that were repli-
cating, we observed no apparent organellar defects (e.g., dense
granule, apicoplast, mitochondria, rhoptries, or IMC) or dysregu-
lation of endodyogeny as examined by IFA at various time points
(data not shown). Together, these data indicate that loss ofGRA39
severely disrupts parasite growth in vitro. Similarly, gra38 and
gra40 parasites were analyzed by competition and plaque assays,
but these strains showed no apparent growth or replication defects
(not shown).
Deletion of GRA39 results accumulation of lipids in the PV,
generation of amylopectin granules in the parasite cytoplasm,
and parasite death. To better examine the phenotype of the
GRA39 knockout on an ultrastructural level, we examined intra-
cellular wild-type, gra39, and GRA39c parasites by transmission
electron microscopy (Fig. 6). We found that gra39 parasites ac-
cumulated dramatic osmiophilic lipid deposits within the parasi-
tophorous vacuole (Fig. 6C and D, yellow arrowheads). We were
also able to visualize lipid material in the PV by fluorescence stain-
ing with the lipophilic dye Nile Red (Fig. 6E). These lipid deposits
were not present in either wild-type or GRA39c parasites (Fig. 6A,
B, and E). We additionally noticed that some of the gra39 para-
sites had increased levels of amylopectin granules in the cytoplasm
TABLE 3 Summary of known and novel GRAs found by GRA13-BioIDa
Gene ID (TgGT1 no. [ToxoDB version 7.3]) Gene ID (TgGT1 no. [ToxoDB release 25]) Protein name
083030 227620 GRA2
058380 237880 GRA13
017550 203310 GRA7
108770.0 270240 MAG1
034740 288650 GRA12
108780.0 270250 GRA1
017570 203290 GRA34
004030 254470 MYR1
087090 310780 GRA4
125960.0 215220 GRA22
072150 212300 GRA32
051100 239740 GRA14
096230 297880 GRA18
021470 208450 TgPI-1
032340 290700 GRA25
102940 251540 GRA9
088710 312420 GRA38
069040 236890 GRA37
033840 289380 GRA39
014920 220240 GRA31
004270 254720 GRA8
115760 232000 GRA30
021860 208830 GRA16
030810 219810 GRA40
082670 227280 GRA3
039660 213067 GRA36
064850 410370, 279100, 279100A, 279100B, 411470, 220950 MAF1-related protein
053890 410360 MAF1-related protein
115800 231960 GRA28
108120 269690 GRA29
081550 226380 GRA35
068050 275470 GRA15
a Novel GRAs 28-40 are highlighted in boldface.
FIG 3 Triton X-114 fractionation of GRAs 38, 39, and 40. Triton X-114 (T) phase partitioning shows that GRA38, GRA39, and GRA40 are preferentially found
in the aqueous (Aqu [soluble]) phase with the soluble marker ROP1, whereas the glycosylphosphatidylinositol (GPI)-anchored SAG1 remained in the detergent
(Det [membrane]) fraction. Detergent lysis and fractionation were performed on intracellular parasites.
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of the parasite (Fig. 6D, red arrow) and also observed the cluster-
ing of host lipid vacuoles around the PV (Fig. 6C, D, and F, aster-
isks). The GRA39 knockout also resulted in a substantial number
of vacuoles that contained dying parasites, as evidenced by loss of
plasma membrane integrity, poorly identifiable intracellular
structures, and abnormal enlargement of the PV space (Fig. 6F).
These dying parasites could often be observed alongside healthy
parasites with normal PVs in the same host cell, indicating that the
host microenvironment was not the cause of parasite death (not
shown). In knockout parasites that appeared to replicate within
vacuoles (albeit more slowly), organelles, including the dense
granules, exhibited normal morphology. The ultrastructure of the
intravacuolar network was intact (Fig. 6G), and the presence of
host organelles such as mitochondria associated with the PVM
was also unaffected by GRA39 deletion (Fig. 6A to D, white ar-
rows).
As GRA38 is closest in sequence similarity to GRA39 and may
play a similar role in Toxoplasma infections, we attempted to gen-
erate a GRA38 GRA39 double knockout. To do this, we first re-
moved the HXGPRT gene from the gra38 parasite by homolo-
gous recombination (see Fig. S3 in the supplemental material) and
then attempted to delete GRA39 from the gra38 hxgprt strain.
We attempted to generate the double knockout using both ho-
mologous recombination and clustered regularly interspaced
short palindromic repeats (CRISPR) with Cas9, screening popu-
lations and individual clones using our polyclonal rat anti-GRA39
antibody. After multiple attempts with different strategies (see
Materials and Methods), we were unable to isolate a viableGRA38
GRA39 deletion mutant, suggesting that the tandem loss of these
genes is lethal to the parasite.
GRA39 is critical for virulence in mice. To evaluate whether
the growth defect of gra39 mutants observed in vitro translated
into a virulence defect in vivo, we carried out parallel infections of
GRA39-HA, gra39, and GRA39c parasites in C57BL/6 mice. In-
fected mice were observed for symptoms of infection, weight loss,
and morbidity. Mortality for mice infected with the GRA39-HA
parental line was consistent with previously published virulence
studies with type II parasites, with a 50% lethal dose (LD50) of
~103 to 104 (25) (Fig. 7A). Mice infected with a dose of 50,000
GRA39-HA parasites exhibited 100% mortality by day 11 postin-
fection. In sharp contrast, mice infected with either 5,000, 50,000,
or 500,000 gra39 parasites all survived to the end of the experi-
ment (21 days) (Fig. 7B). Symptoms of infection were also less
severe in mice infected with gra39 parasites. These mice gener-
ally moved with less impairment, had less ruffled coats, and lost
less weight than mice infected with the parental and GRA39c lines
(see Fig. S4 in the supplemental material). As with in vitro exper-
FIG 4 Targeted disruption of the gene encoding GRAs 38, 39, and 40. (A) Schematic depicting the GRA knockout strategy. Using homologous recombination,
the GRA coding region was replaced with the selectable marker gene HXGPRT. (B) IFA of gra38, gra39, and gra40 parasites demonstrating a lack of HA
staining, but not GRA14, in the PV. (C) Western blot analysis of lysates of gra38, gra39, and gra40 parasites and their respective parental strains. ROP13 is
used as a loading control. KO, knockout.
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iments, this virulence defect reverted upon complementation of
GRA39 (Fig. 7C).
To evaluate the role of GRA39 during the chronic infection, we
examined brain cyst burden in surviving mice after 30 days. While
the parental Pruku80hxgprt strain makes low numbers of cysts
in C56BL/6 mice, higher cyst numbers can be obtained in CBA/J
mice (26, 27). Thus, we repeated the infections in CBA/J mice with
GRA39-HA, gra39, and GRA39c parasites and examined the
brains from the euthanized mice after 30 days of infection. Using
this approach, we were able to quantitate the number of brady-
zoite cysts and found that brains fromgra39 strain-infected mice
contained approximately 100-fold-lower numbers of cysts than
those infected with GRA39-HA and GRA39c lines, even with a
100-fold-higher inoculum of the gra39 strain (Fig. 7D and E).
The cysts obtained fromgra39 parasites appeared to be morpho-
logically normal upon gross examination (not shown), suggesting
that the defect is limited to the cyst burden in gra39 parasites,
rather than viability of the cysts themselves.
We next examined the ability of this line to form bradyzoite
cysts in vitro using pH shift (pH 8.1) (28). We found that gra39
parasites were able to form in vitro cysts as efficiently as
GRA39-HA and GRA39c parasites (data not shown). In addition,
FIG 5 Disruption of GRA39 results in a slow-growth phenotype of Toxoplasma in vitro. (A) Complementation strategy of GRA39 into the UPRT locus. The
complemented gene contains a C-terminal 3HA epitope tag and is driven by the tubulin promoter. (B) IFA of GRA39-HA, gra39, and GRA39c parasites.
Rabbit anti-HA shows strong staining in the vacuole of GRA39-HA and GRA39c parasites, colocalizing with GRA14. HA signal is absent ingra39 parasites. Scale
bar, 10m. (C) Western blot demonstrating GRA39 migrating as a single band at the predicted size of ~103 kDa (size of GRA39 after signal peptide cleavage and
the addition of the 3HA tag). GRA39c parasites demonstrate a significant overexpression of the protein driven by the tubulin promoter. (D) Competition assay
of GRA39-HA and gra39 parasites. Parasites were initially mixed in an 80/20 ratio (HA/knockout) and then passaged serially after lysis of the host cell
monolayer. Vacuoles from the mixed population were enumerated at each passage. Each data point represents 100 random vacuoles counted, with 3 replicates
per data point. Error bars indicate 3 the standard deviation. (E) Quantitation of plaques formed by GRA39-HA, gra39, and GRA39c parasites. Results are
shown as box-whisker plots, with the middle line representing the median, the bottom and top of the box representing the 25th and 75th percentiles, respectively,
and the whiskers corresponding to smallest and largest plaques. Each bar of the graph represents an average of means across experimental replicates (n 3 for
all conditions), and two-sample two-tailed t tests were performed comparing each condition to GRA39-HA to assess statistical significance (***, P 0.0006). (F)
Phase microscopy images of representative plaques made by GRA39-HA, gra39, and GRA39c parasites in HFF monolayers. Cells were fixed in methanol and
stained with crystal violet. Scale bar, 500m. (G) Counts of parasites/vacuole done after 36 h of infection of GRA39-HA,gra39, and GRA39c parasites. A total
of 100 vacuoles were quantitated per parasite line, with three replicate counts completed. Bars represent mean parasite/vacuole count, with error bars showing
1 standard deviation from each mean. Statistical significance comparing each line to GRA39-HA was calculated for 16 parasites/vacuole using a two-sample
two-tailed t test (**, P 0.003). The occurrence of 1 parasite/vacuole was not counted for any line, as it could not be determined whether or not these were viable
events.
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we noticed that the GRA39 signal at the PV was more faint by IFA
in in vitro encysted GRA39-HA bradyzoites in vitro than in
tachyzoites, in agreement with a downregulation of GRA39 tran-
scription during the bradyzoite stage (29, 30), suggesting that this
protein likely does not have an important role in chronic infec-
tion. Together, these data demonstrate that GRA39 likely serves a
role in the normal replication of parasites and that the gra39
mutant has difficulty establishing a chronic infection due to its
inability to replicate at a normal rate.
DISCUSSION
The parasitophorous vacuole serves as an interface between the
parasite and its host cell (8, 17). The vacuolar membrane is semi-
permeable due to a membrane pore comprised of GRAs 17 and 23,
which allows for the exchange of small molecules (~1,300 to
1,900 Da), enabling uptake of nutrients from the host cell (10).
GRAs 17 and 23 are also related to the Plasmodium translocon
component EXP2, and thus they may also play roles in protein
export from the PV into the host cell (10). Inside the PV, GRAs 2,
4, and 6 participate in the formation of the IVN, which is believed
to traffic nutrients as well as maintain a semirigid supporting scaf-
fold for the vacuole (9, 12, 13). An array of other GRAs are present
in the PV, PVM, and IVN, but their precise roles in intracellular
survival are not well defined. As many of these GRAs are not con-
served outside Toxoplasma and its closest relatives (e.g., Neospora
and Hammondia), their functions are likely specialized for the
intracellular niche of this group, rather than common functions of
apicomplexan parasites as a whole (6). Uncovering the proteome
of the PV can therefore not only reveal the survival mechanisms of
T. gondii but also may expose a number of novel parasite-specific
drug targets.
In spite of its central role in Toxoplasma growth and survival,
the PV has been challenging to study due to excessive parasite
and/or host contamination using traditional biochemical frac-
tionation approaches (31, 32). The BioID method has enabled us
to specifically label the PV constituents by in vivo biotinylation,
therefore circumventing the need for fractionations (19, 20). We
initially chose GRA17 as the bait protein because it is highly ex-
pressed, and thus we envisioned that it would be able to label a
broad array of proteins in the PV. GRA17 is proposed to function
in conjunction with its paralog GRA23 at the PVM, as either
hetero- or homomultimeric complexes (10). In agreement with
this, GRA23 scored highly in the mass spectrometry data set (Ta-
ble 1; see Table S1 in the supplemental material). However, a
number of other GRAs ranked highly in our data set, thus differ-
entiating between interacting and proximal proteins will require
FIG 6 Deletion of GRA39 results in accumulation of lipid deposits in the PV, generation of amylopectin granules in the parasite cytosol. (A to D) Transmission
electron micrographs demonstrating wild-type (A), GRA39c (B), and gra39 (C and D) parasites within parasitophorous vacuoles. The gra39 line shows
accumulation of osmiophilic lipid deposits within the parasitophorous vacuole (yellow arrowheads) and amylopectin granules within the parasite cytosol (red
arrow in panel D). Increased amounts of lipid droplets were also found in the host cytosol proximal to the PV (asterisks). The association of mitochondria with
the PV remained intact in all three lines (white arrows). Scale bars, 500 nm. (E) Nile Red staining of intracellular parasites, once again demonstrating an
accumulation of neutral lipids within the PV (gra39, yellow arrowheads). (F) Transmission electron micrograph of gra39 parasites showing signs of death in
an enlarged PV. (Host lipid vacuoles are indicated by asterisks.) Scale bar, 500 nm. (G) Transmission electron micrograph of intracellular gra39 parasites
illustrating the normal ultrastructure of the IVN, close to the PVM, between two parasites (P). Scale bar, 250 nm.
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independent experiments. We also examined the GRA17-BioID
hits for other proteins that might be similar to the Plasmodium
PTEX complex (e.g., heat shock protein 101 [HSP101] and thiore-
doxin 2) (33–36). While the HSP-related ER protein BIP (HSP70
[TgGT1_311720]) (37, 38) was labeled in our experiment, no
other putative HSPs containing signal peptides were found that
might represent a vacuolar heat shock protein similar to HSP101.
It is likely that BIP was labeled by GRA17-BirA*, while the fusion
protein trafficked through the secretory pathway, as evidenced by
the biotinylation of proteins such as signal peptidase (TgGT1_
300060). We did identify four thioredoxin-like proteins contain-
ing predicted signal peptides (TgGT1_209950, TgGT1_204480,
TgGT1_247350, and TgGT1_224060), none of which have been
characterized. In addition, we identified GRA16 and GRA24, both
of which are exported into the host cell and transit to the host
nucleus, as well as GRA15 and MAF1, which are inserted into the
vacuolar membrane and are exposed to the host cytoplasm (15,
16, 39, 40). Like GRA23, the extent to which these are truly pro-
teins that interact with GRA17 or merely proximal at the vacuolar
membrane remains to be determined.
To evaluate the extent of vacuolar labeling with different GRA
bait proteins, we replicated the GRA17-BioID experiment with
GRA25 and GRA13. These GRA-BioID experiments also labeled a
wide array of previously known and novel GRA proteins. As ex-
pected, the overlap between these experiments was not perfect,
with some GRAs appearing only in one experiment or another
(e.g., GRA5 was found in the GRA17-BirA* experiment alone, and
GRAs 17, 12, 24 appeared only in GRA17- and GRA25-BirA* ex-
periments). While the data suggest broad labeling of the vacuole,
the ranking of individual proteins (by NSAF) in the data sets likely
reflects both their proximity to the GRA-BirA* fusion proteins
and their overall abundance. The high success rate of our verifica-
tions by endogenous gene tagging supports specific labeling of
GRAs secreted into the PV. Many of the novel GRAs contain pre-
dicted transmembrane domains (GRAs 30, 31, 33, 35, and 36).
This is expected, as many GRAs anchor into the IVN or PV mem-
brane, and both the GRA17 and GRA25 bait proteins are also
membrane associated (8). Of these, GRAs 33 and 36 demonstrated
a particularly strong IFA signal on the PV membrane (Fig. 2).
Many GRAs are known to be antigenic as antibodies against these
secreted proteins are found to be peptide ligands for major histo-
compatibility complex (MHC) class I receptors (41). Indeed,
GRA4 and GRA7 have also been heavily researched as vaccine
candidates. A recent examination of Toxoplasma peptide ligands
to HLA-A*2:01 that 15% of verified ligands were GRAs, including
MAG1 and NTPase II. Not surprisingly, we found in examining
FIG 7 GRA39 is critical for virulence and normal brain cyst burden in mice. (A to C) Groups of 4 C57BL/6 female mice each were infected with indicated doses
of GRA39-HA (A), gra39 (B), and GRA39c (C) parasites, and survival was monitored. Kaplan-Meier survival curves were generated. Mice infected with
GRA39-HA and GRA39c parasites died in a dose-dependent manner over time (A and C). However, all mice infected withgra39 parasites survived throughout
the full 21 days of the observation period (B). Surviving mice were euthanized after 30 days of observation. Mantel-Cox log rank test was used for the following
comparisons: GRA39-HA parasites at 5,000 parasites/mouse versus gra39 parasites at 5,000, 50,000, or 500,000 parasites/mouse, P  0.039; GRA39-HA at
50,000 parasites/mouse versusgra39 at 50,000 or 500,000 parasites/mouse, P 0.008. (D and E) Bradyzoite cysts were quantitated from brains extracted from
CBA/J mice sacrificed after 30 days of infection with GRA39-HA,gra39, and GRA39c parasites. (Groups of 4 mice per experiment were used.) Althoughgra39
parasites were able to establish a chronic infection, the cyst burden was greatly decreased compared to that in infection with the GRA39-HA and GRA39c lines.
Statistical significance of the difference in cyst burden between strains and infections was calculated using a two-sample two-tailed t test comparing all
experiments to GRA39-HA (500 parasites/mouse) infection: ***, P 0.03.
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their data that novel GRAs 28, 29, 32, and 39 were also MHC class
I ligands, further stressing the importance of these secreted pro-
teins in the host immune response (41).
As expected, most of the GRAs identified were expressed pre-
dominantly in tachyzoites or equally in tachyzoites and brady-
zoites. However, GRAs 30 and 34 are upregulated in bradyzoites,
which may suggest that they play roles in the transition to brady-
zoites or that their function is primarily in the cyst form of the
parasite. Similarly, we found that the predominantly bradyzoite
protein MAG1 (42) ranked very highly in our spectral analysis,
suggesting that this protein is also present in tachyzoites. This
finding agrees with in vivo studies and mass spectrometry data
indicating MAG1 is expressed in the tachyzoite stage of the para-
site (43). The use of bradyzoite GRA proteins as bait in encysted
parasites in future BioID studies promises to be a powerful ap-
proach to identify secreted vacuolar proteins that function in the
formation or maintenance of the bradyzoite cyst.
While most of the GRAs identified to date lack paralogs in
Toxoplasma (8), we identified a group of new GRA proteins
(GRAs 38 to 40) that have shared sequence similarity. The levels of
similarity are relatively low, with GRAs 38 and 39 being the most
similar to one another (E value, 6  1010), whereas GRA40 is
more distantly related to both GRAs 38 and 39 (E values, 2 104
and 7 104, respectively). As is observed with many GRAs, these
proteins lack identifiable domains that might provide clues to-
ward their function, and they are unique to Toxoplasma and its
closest coccidian relatives (e.g., Hammondia,Neospora, and Eime-
ria). It is noteworthy that GRAs 38 to 40 are significantly larger
than most previously identified GRAs (~100 kDa versus the 30 to
50 kDa typical of most GRA proteins) and appear to be soluble
components of the PV (Fig. 3) (8). We addressed the function of
these new players by gene disruption and showed that none of
these proteins is individually essential for parasite survival. How-
ever, we were unable to generate a double knockout of GRAs 38
and 39, indicating at least partial functional redundancy and these
two most closely related players are essential for parasite survival.
Disruption of GRA39 resulted in a strong growth defect and
the appearance of striking deposits of lipid material in the PV,
which suggests that GRA39 could function in the utilization of
lipids from the vacuolar space into the parasite, although other
effects on vacuolar lipid regulation are also possible. The accumu-
lation of host lipid droplets around the PV may be additional
evidence linking the phenotype of the GRA39 knockout with par-
asite lipid metabolism. The gra39 parasites also showed an in-
crease in amylopectin granules, which are present during times of
nutritional stress and in which the parasite relies on gluconeogen-
esis to acquire carbon (44, 45). These granules are often seen in the
slow-growing bradyzoite stage of the parasite and thus may be
linked to slow growth in the gra39 parasites (although it is im-
portant to note that the knockout does not show enhanced switch-
ing to bradyzoites). If GRA39 is indeed important for metabolism,
this would also explain our observation that a small percentage of
knockout parasites die shortly after invasion; this would likely be
due to starvation as the parasite is unable to acquire the nutrient it
needs to complete endodyogeny. The dramatic reduction in viru-
lence in the knockout is likely a consequence of the slow growth of
the mutant strain, as well as a higher rate of parasite death, which
together enable the host to better control the infection. Disruption
of GRA39 also has an effect on the chronic infection, which dis-
plays a sharply reduced brain cyst burden during infections in
vivo. This may be due to changes in tissue tropism in the knock-
out or more simply another effect of the growth defect in the
knockout.
The development of GRA39 knockout parasites also provides a
foundation for identification of domains important for function
by mutagenesis and subsequent complementation, which will
help to determine the precise role of this protein in Toxoplasma
growth and virulence. Together, the adaptation of the BioID ap-
proach for the identification of novel GRAs and the discovery of
GRAs 38 to 40 open new insight into the arsenal of GRAs that
enable Toxoplasma to survive in its intracellular niche and cause
disease.
MATERIALS AND METHODS
Host cell and parasite cultures.T. gondii strains RHhxgpt (type I, strain
RH), Pruku80hxgprt (type II, strain Prugniaud), and modified strains
were used to infect human foreskin fibroblast (HFF) cells. HFFs were
grown in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum and 2 mM glutamine and maintained as previously
described (46).
Antibodies. The primary antibodies used in immunofluorescence as-
says (IFAs) and Western blotting were mouse polyclonal anti-GRA14 (1:
1,000) (21), rabbit anti-HA (Covance [1:2,000]), rabbit polyclonal anti-
ROP13 (1:500) (47), and rat polyclonal anti-GRA39 (1:1,000). For
generation of anti-GRA39 antisera, the full coding region of GRA39 was
PCR amplified from Prugniaud strain cDNA using primers p41 and p42
(see Table S6 in the supplemental material). This product was ligated in
frame into pet-28a, which contains both N-terminal and C-terminal poly-
histidine tags, using EcoRI and NotI and transformed into BL21
Star(DE3) chemically competent Escherichia coli cells. Protein expression
was induced with IPTG (isopropyl--D-thiogalactopyranoside) and pu-
rified using Ni-nitrilotriacetic acid (NTA) agarose beads under denatur-
ing conditions. The eluted protein was then dialyzed to remove urea and
injected into a rat for antibody production (Cocalico Biologicals).
IFA and Western blotting. For IFA, HFFs were grown to confluence
on coverslips and infected with T. gondii parasites. After 18 to 36 h, the
coverslips were fixed and processed for indirect immunofluorescence as
previously described (32). Primary antibodies were detected by species-
specific secondary antibodies conjugated to Alexa Fluor 594/488. The cov-
erslips were mounted in ProLong Gold antifade reagent (Thermo, Fisher)
and viewed with an Axio Imager Z1 fluorescence microscope (Zeiss) as
previously described (21). For Western blotting, parasites were lysed in
Laemmli sample buffer (50 mM Tris-HCl [pH 6.8], 10% glycerol, 2%
SDS, 1% 2-mercaptoethanol, 0.1% bromophenol blue), and lysates were
resolved by SDS-PAGE and transferred onto nitrocellulose membranes.
Blots were probed with the indicated primary antibodies, followed by
secondary antibodies conjugated to horseradish peroxidase (HRP). Tar-
get proteins were visualized by chemiluminescence.
Nile Red staining. Confluent HFF monolayers on coverslips were in-
fected with T. gondii parasites. Thirty-six hours postinfection, the cover-
slips were fixed in 4% paraformaldehyde and stained with 0.5 g/ml Nile
Red as previously described (48, 49). The coverslips were then mounted
onto slides in Vectashield antifade reagent and viewed as described above.
Transmission electronmicroscopy.HFFs infected with the wild-type
Prugniaud, gra39, or GRA39c strain for 26 h were fixed in 2.5% glutar-
aldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) for 1 h at room
temperature and processed as described (50) before examination with a
Philips CM120 electron microscope (Eindhoven, The Netherlands) under
80 kV.
Generation of GRA17-, GRA25-, andGRA13-BirA* fusions. To gen-
erate the GRA17-BirA* fusion, the full GRA17 gene and promoter were
PCR amplified from genomic DNA (primers p1 and p2; see Table S6 in the
supplemental material). This was cloned into the p.LIC.BirA*.3
HA.DHFR vector by ligation independent cloning as previously described
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(20). Thirty micrograms of the construct was linearized with HindIII and
transfected into RH hxgprt parasites. The parasites were selected with
medium containing 1 M pyrimethamine, cloned by limiting dilution,
and screened by IFA and Western blotting against the HA tag. A clone
expressing the fusion protein was selected and designated GRA17-BirA*.
To generate the GRA25-BirA* and GRA13-BirA* fusions, the procedure
described above was replicated using the PCR-amplified genomic regions
of the respective genes. For GRA25-BirA*, ~900 bp of the 3= genomic
region was used (p5 and p6); for GRA13-BirA* the whole of the genomic
region was used along with a portion of the promoter (p3 and p4).
GRA25-BirA* and GRA13-BirA* constructs were transfected into Pru
ku80 hxgprt parasites, and clones were generated as described above.
Affinity capture of biotinylated proteins. HFF monolayers were in-
fected with parasites expressing BirA* fusions or the respective parental
line (RH hxgprt for GRA17-BirA* and Pru ku80 hxgprt for GRA13-
and GRA25-BirA*) for 12 h and then grown in medium containing 150
M biotin for an additional 24 h (20). Infected cells were collected by
manual scraping, washed in phosphate-buffered saline (PBS), and lysed in
radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris [pH 7.5],
150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40) sup-
plemented with Complete protease inhibitor cocktail (Roche) for 30 min
on ice. Lysates were centrifuged for 15 min at 14,000 g to pellet insoluble
material, and the supernatant was incubated with Streptavidin Plus Ul-
traLink resin (Pierce) at room temperature for 4 h under gentle agitation.
Beads were collected and washed five times in RIPA buffer, followed by
three washes in 8 M urea buffer (50 mM Tris-HCl [pH 7.4], 150 mM
NaCl). Ten percent of each sample was boiled in Laemmli sample buffer,
and eluted proteins were analyzed by Western blotting by streptavidin-
HRP, while the remainder was used for mass spectrometry.
Mass spectrometry of biotinylated proteins.Purified proteins bound
to streptavidin beads were reduced, alkylated, and digested by sequential
addition of trypsin protease (51, 52). The peptide mixture was desalted
using C18 tips and fractionated online using a 75-m-inner-diameter frit-
ted fused silica capillary column with a 5-m pulled electrospray tip and
packed in house with 15 cm of Luna C18 (2) 3-m reversed-phase parti-
cles. The gradient was delivered by an easy-nLC 1000 ultrahigh-pressure
liquid chromatography (UHPLC) system (Thermo Scientific) (53, 54).
Tandem mass spectrometry (MS/MS) spectra were collected on a
Q-Exactive mass spectrometer (Thermo Scientific). Data analysis was per-
formed using the ProLuCID and DTASelect2 implemented in the Inte-
grated proteomics pipeline IP2 (Integrated Proteomics Applications, Inc.,
San Diego, CA) (55, 56). Protein and peptide identifications were filtered
using DTASelect and required a minimum of two unique peptides per
protein and a peptide-level false-positive rate of less than 5%, as estimated
by a decoy database strategy (57). Normalized spectral abundance factor
(NSAF) values were calculated as described previously (58).
Generation of GRA-HA parasites (epitope tagging of BioID hits).
Candidate GRA proteins identified by mass spectrometry were selected
based on the presence of a signal peptide using SignalP 4.1 software
(http://www.cbs.dtu.dk/services/SignalP/). Candidates were further nar-
rowed for those with constitutive cell cycle RNA expression profiles in
tachyzoites and lacked C-terminal endoplasmic reticulum localization se-
quences (K/HDEL or similar). To epitope tag the novel GRAs, ~1,500 bp
of the 3= genomic region of each gene was amplified using the primers
listed in Table S6 in the supplemental material (primers p7-p28, p33-p34,
and p43-44) from Pru ku80 hxgprt genomic DNA. The products were
cloned into the p.LIC.3HA.DHFR vector to add a 3HA tag on the
target gene as previously described (59–61). The constructs were linear-
ized, and 50 g of DNA was transfected by electroporation into the Pru
ku80hxgprt strain ofT. gondii. The transfected parasites were grown in
medium containing 1 M pyrimethamine, and selected parasites were
cloned by limiting dilution. Clones were designated “GRA(X)-HA,”
where “X” represents the protein number (e.g., GRA30-HA). All con-
firmed GRAs were examined in silico by BLAST to search for other Toxo-
plasma proteins with sequence similarity.
Triton X-114 detergent extraction. Intracellular parasites were lysed
in precondensed Triton X-114. Precondensation was performed as previ-
ously described (62). Briefly, after 20 min of lysis on ice, the insoluble
portion was removed by high-speed centrifugation (3,000 g for 10 min
at 4°C). Subsequently, the lysate was warmed to 30°C for 5 min to achieve
the cloud point. Micelles (detergent fraction) were then separated from
the aqueous fraction by centrifugation of the lysate at 30°C (3,000 g for
10 min). The fractions were examined by SDS-PAGE and Western blot-
ting for the HA-tagged target proteins, using SAG1 and ROP1 as the
detergent and aqueous controls, respectively.
Deletion of the genes encoding GRA38, GRA39, and GRA40. For
disruption of GRAs 38, 39, and 40, genomic sequences flanking the re-
spective genes were amplified from T. gondii Pru ku80 hxgprt strain
genomic DNA and subcloned into the p.mini-GFP.hxgprt.ht vector (for
the sequences of primers p29-32, p35-39, and p45-50, see Table S6 in the
supplemental material) (59, 60). This vector contains the selectable
marker hypoxanthine-xanthine-guanine phosphoribosyl transferase gene
(HXGPRT) and a green fluorescent protein (GFP) cassette located down-
stream for negative selection of heterologous recombinants. The final
constructs were linearized, and 50 g of DNA was transfected by electro-
poration into the respective parental HA-tagged strain. The transfected
parasites were grown in medium containing 50 g/ml MPA (mycophe-
nolic acid) and 50 g/ml xanthine and cloned by limiting dilution. GFP-
negative parasites were then screened by IFA and confirmed by Western
blotting using mouse anti-HA antibodies. The knockouts were further
verified by PCR (p27-28, p39, p43-44, and p49-55 in Table S6 and see
Fig. S3 in the supplemental material). To attempt to generate a gra38
gra39 mutant, we first removed the HXGPRT cassette from the
p.mini.gra38 knockout plasmid (see Fig. S3A). We then transfected this
plasmid into gra38 parasites, and selected HXGPRT-negative clones us-
ing 6-thioxanthine selection. Loss of HXPGPRT was confirmed by PCR
(p49 and p50 in Table S6 and see Fig. S2A in the supplemental material).
Subsequently, we attempted to delete GRA39 in the gra38 hxgprt mu-
tant using three separate strategies. We first attempted to isolate a clone by
transfecting the p.mini.gra39.hxgprt construct used for the single knock-
out. Second, we attempted to use CRISPR-Cas9 using a guide RNA
(gRNA) directed toward the GRA39 locus and introducing an HXGPRT
cassette to replace the entire coding region using homologous recombi-
nation with 5= and 3= flanks of GRA39 as previously described (63). Fi-
nally, we again attempted CRISPR-Cas9 deletion, again using a gRNA
directed toward the first intron of GRA39; however, this time replacing a
portion of the coding sequence with 3 in-frame stop codons and intro-
ducing a frameshift mutation using an 80-bp double-stranded oligonu-
cleotide (64).
Complementation of GRA39. GRA39-HA was reintroduced into the
genome of the gra39 line in the uracil phosphoribosyltransferase locus
(UPRT) (24). This was done by amplifying the GRA39-3HA gene from
genomic DNA of the GRA39-HA parasite line. The PCR product was
cloned into the UPRT knockout vector with a tubulin promoter added
using PacI and NsiI, forming a construct with the GRA39-3HA cassette
inserted between the UPRT locus 5= and 3= flanking regions (see Table S6,
primers p39-40). This plasmid was linearized using XbaI and transfected
into gra39 parasites and selected with 5-fluoro-5=-deoxyuridine
(FUDR) to isolate parasites with the construct integrated at the UPRT
locus (65). Clones were selected by limiting dilution and examined by IFA
(anti-HA antibody), and a positive clone was designated GRA38c.
Growth competition/mixing assay.GRA39-HA andgra39 parasites
were mixed in an initial 20/80 ratio and passaged. After each lysis (an
average of 48 to 60 h), the mixed population was passed into a new HFF
monolayers and screened by IFA to examine the ratio of GRA39-HA to
gra39 vacuoles. Three replicates of 200 vacuoles each were counted, and
the percentage of HA versus knockout parasites was calculated (66).
Plaque assay. Serial dilutions of GRA39-HA, gra39, and GRA39c
parasites were used to infect separate wells of a 24-well plate with an HFF
monolayer and allowed to form plaques. The dilutions were calibrated to
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infect at 20 parasites/well, 60 parasites/well, and 120 parasites/well.
Six days after infection, HFF monolayers were fixed in 3.7% formaldehyde
for 15 min, washed with PBS, dried, and stained with crystal violet.
Plaques were then visualized with a Zeiss upright light microscope (Zeiss
Axio Imager Z1). Plaque areas were measured using ZEN software (Zeiss),
and GRA39-HA,gra39, and GRA39c plaque sizes were compared. Three
separate experiments with 30 plaques for each parasite line were measured
to generate a mean plaque size along with interquartile ranges. Statistical
significance comparing the GRA39-HA line to the other strains was cal-
culated using a two-sample two-tailed t test.
Parasite-per-vacuole assay. HFF coverslips were infected separately
with GRA39-HA, gra39, and GRA39c parasites, and incubated for 36 h.
The samples were then fixed in 100% methanol and stained using primary
mouse anti-SAG1 antibody and FITC-conjugated secondary goat anti-
mouse secondary antibody. Vacuoles were examined for parasite count
(2, 4, 8, or16 parasites/vacuole) and scored. In total, 100 vacuoles were
counted per parasite line. This experiment was repeated in triplicate to
generate a mean and standard deviation (67), and statistical significance
between the strains was calculated for16 parasites/vacuole using a two-
sample two-tailed t test.
Mouse virulence assays. Intracellular GRA39-HA, gra39, and
GRA39c parasites mechanically liberated from infected HFF monolayers
and resuspended in Opti-MEM reduced serum medium (Thermo, Fisher
Scientific) prior to intraperitoneal injection into groups of 4 female
C57BL/6 mice per line per dose (e.g., 4 mice were injected each with 500
GRA39-HA parasites, 4 mice each injected with 5,000 GRA39-HA para-
sites, etc.). Injected parasites were confirmed to be live and viable by
plaque assays with HFF monolayers. Mice were monitored for symptoms
of infection, weight loss, and mortality for 21 days. Survival was plotted on
a Kaplan-Meier curve. Surviving mice were sacrificed at 30 days after
infection, and mouse brains were collected in aseptic fashion, homoge-
nized, and examined by phase microscopy and fluorescence microscopy
(for detection of GFP under the LDH2 promoter for parasite encystation).
In parallel, 1/3 of each brain was homogenized and incubated with HFF
monolayers to qualitatively assess viability of parasites.
Mouse brain cyst quantitation. Intracellular GRA39-HA, gra39,
and GRA39c parasites were mechanically liberated from infected HFF
monolayers and resuspended in Opti-MEM prior to intraperitoneal in-
jection into groups of 4 female CBA/J mice each. A total of 500 parasites/
mouse of GRA39-HA and GRA39c and two separate doses (500 parasites/
mouse and 50,000 parasites per mouse) of thegra39 strain were injected.
The mice were monitored for 30 days after infection and then sacrificed.
Mouse brains were collected, homogenized, and examined for T. gondii
cysts (as described above). Quantitation of cysts was performed by exam-
ining 25-l aliquots of homogenate by fluorescence microscopy until ap-
proximately 25% (by volume) of each brain was examined. Total cyst
burden was then extrapolated. The statistical significance of cyst burden
between GRA39-HA,gra39, and GRA39c experiments was calculated by
two-sample 2-tailed t test.
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of the Animal Welfare Act and the PHS Policy on Humane Care and Use
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